Terms: = Cervical cancer AND KMT2A, TRX1, 4297, MLL, ENSG00000118058, MLL/GAS7, HTRX1, HRX, ALL-1, MLL1A, CXXC7
26 results:
1. Mutational landscape of head and neck cancer and cervical cancer in Chinese and Western population.
Li Q; Zhu G; Zhang L; Zeng B; Cai T; Wu J; Wei B; Xie Z; He L; Tang W; Lin X; Lu H; Wu F; Huang J; Hu H; Liu N; Fan S
Head Neck; 2024 Mar; 46(3):528-540. PubMed ID: 38111234
[TBL] [Abstract] [Full Text] [Related]
2. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
3. Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women.
Onuki M; Yamamoto K; Yahata H; Kanao H; Yokota H; Kato H; Shimamoto K; Takehara K; Kamiura S; Tsuda N; Takei Y; Shigeta S; Matsumura N; Yoshida H; Motohara T; Watari H; Nakamura K; Ueda A; Tasaka N; Ishikawa M; Hirashima Y; Kudaka W; Taguchi A; Iwata T; Takahashi F; Kukimoto I; Yoshikawa H; Yaegashi N; Matsumoto K;
Cancer Sci; 2022 Apr; 113(4):1428-1434. PubMed ID: 35043515
[TBL] [Abstract] [Full Text] [Related]
4. The blood level of thioredoxin 1 as a supporting biomarker in the detection of breast cancer.
Lee YJ; Kim Y; Choi BB; Kim JR; Ko HM; Suh KH; Lee JS
BMC Cancer; 2022 Jan; 22(1):12. PubMed ID: 34979986
[TBL] [Abstract] [Full Text] [Related]
5. Correlates of premature pap test screening, under 25 years old: analysis of data from the CONSTANCES cohort study.
Mignot S; Ringa V; Vigoureux S; Zins M; Panjo H; Saulnier PJ; Fritel X
BMC Public Health; 2021 Mar; 21(1):595. PubMed ID: 33765986
[TBL] [Abstract] [Full Text] [Related]
6. Expanding the phenotype of Wiedemann-Steiner syndrome: Craniovertebral junction anomalies.
Giangiobbe S; Caraffi SG; Ivanovski I; Maini I; Pollazzon M; Rosato S; Trimarchi G; Lauriello A; Marinelli M; Nicoli D; Baldo C; Laurie S; Flores-Daboub J; Provenzano A; Andreucci E; Peluso F; Rizzo R; Stewart H; Lachlan K; Bayat A; Napoli M; Carboni G; Baker J; Mendel A; Piatelli G; Pantaleoni C; Mattina T; Prontera P; Mendelsohn NJ; Giglio S; Zuffardi O; Garavelli L
Am J Med Genet A; 2020 Dec; 182(12):2877-2886. PubMed ID: 33043602
[TBL] [Abstract] [Full Text] [Related]
7. kmt2a regulates cervical cancer cell growth through targeting VDAC1.
Zhang C; Hua Y; Qiu H; Liu T; Long Q; Liao W; Qiu J; Wang N; Chen M; Shi D; Yan Y; Xie C; Deng W; Li T; Li Y
Aging (Albany NY); 2020 May; 12(10):9604-9620. PubMed ID: 32436862
[TBL] [Abstract] [Full Text] [Related]
8. [Knockdown of ACSS2 inhibits invasion and migration of cervical cancer cells induced by nutrient stress and its mechanism].
Su Y; Ling R; Zhou Y; Chen D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Oct; 35(10):926-931. PubMed ID: 31814569
[TBL] [Abstract] [Full Text] [Related]
9. Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study.
Xia C; Hu S; Xu X; Zhao X; Qiao Y; Broutet N; Canfell K; Hutubessy R; Zhao F
Lancet Public Health; 2019 Sep; 4(9):e462-e472. PubMed ID: 31493843
[TBL] [Abstract] [Full Text] [Related]
10. Impact of Initiating Screening Programs on Referral and Management of cervical cancer in Tanzania.
Sedani A; Soliman AS; Msami K; Msemo D; Mwaiselage J; Schmid K; Kahesa C
J Glob Oncol; 2019 Jul; 5():JGO1800052. PubMed ID: 31343933
[TBL] [Abstract] [Full Text] [Related]
11. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
12. Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.
Jeon MJ; Chun SM; Lee JY; Choi KW; Kim D; Kim TY; Jang SJ; Kim WB; Shong YK; Song DE; Kim WG
Endocrine; 2019 Apr; 64(1):130-138. PubMed ID: 30645724
[TBL] [Abstract] [Full Text] [Related]
13. Physician assessed and patient reported urinary morbidity after radio-chemotherapy and image guided adaptive brachytherapy for locally advanced cervical cancer.
Fokdal L; Pötter R; Kirchheiner K; Lindegaard JC; Jensen NBK; Kirisits C; Chargari C; Mahantshetty U; Jürgenliemk-Schulz IM; Segedin B; Hoskin P; Tanderup K
Radiother Oncol; 2018 Jun; 127(3):423-430. PubMed ID: 29784450
[TBL] [Abstract] [Full Text] [Related]
14. The role of Nrf2 and ATF2 in resistance to platinum-based chemotherapy.
Chen J; Solomides C; Simpkins F; Simpkins H
Cancer Chemother Pharmacol; 2017 Feb; 79(2):369-380. PubMed ID: 28120035
[TBL] [Abstract] [Full Text] [Related]
15. Lifestyle and reproductive risk factors associated with anal cancer in women aged over 50 years.
Coffey K; Beral V; Green J; Reeves G; Barnes I;
Br J Cancer; 2015 Apr; 112(9):1568-74. PubMed ID: 25867258
[TBL] [Abstract] [Full Text] [Related]
16. Professionals' role in implementing a cervical cancer screening program.
Viberga I; Engele L; Kojalo U; Santare D
Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(4):69-73. PubMed ID: 25527039
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study.
Acera A; Manresa JM; Rodriguez D; Rodriguez A; Bonet JM; Sanchez N; Hidalgo P; Soteras P; Toran P; Trapero-Bertran M; Lozano I; De Sanjose S
BMC Womens Health; 2014 Jul; 14():86. PubMed ID: 25026889
[TBL] [Abstract] [Full Text] [Related]
18. Suberoylanilide hydroxamic acid-induced HeLa cell death is closely correlated with oxidative stress and thioredoxin 1 levels.
You BR; Park WH
Int J Oncol; 2014 May; 44(5):1745-55. PubMed ID: 24626405
[TBL] [Abstract] [Full Text] [Related]
19. Effect size and cost-effectiveness estimates of breast and cervical cancer screening reminders by population size through complete enumeration of Japanese local municipalities.
Komoto S; Nishiwaki Y; Okamura T; Tanaka H; Takebayashi T
BMC Public Health; 2014 Jan; 14():43. PubMed ID: 24433346
[TBL] [Abstract] [Full Text] [Related]
20. Computerized tomography-guided percutaneous high-dose-rate interstitial brachytherapy for malignant lung lesions.
Sharma DN; Rath GK; Thulkar S; Bahl A; Pandit S; Julka PK
J Cancer Res Ther; 2011; 7(2):174-9. PubMed ID: 21768706
[TBL] [Abstract] [Full Text] [Related]
[Next]
